WASHINGTON (KTVZ) -- Senator Ron Wyden, D-Ore. announced Thursday that he and six other senators have sent a letter to Attorney General Merrick Garland and Drug Enforcement Administrator Anne Milgram, ...

Marijuana products remain federally illegal until approved by the FDA, and only three cannabis-based drugs have received ...

April 30 (UPI) --In a historic move that does not legalize adult-use marijuana nationwide but eases its restrictions, the U.S. Drug Enforcement Administration on Tuesday agreed to reclassify cannabis, ...

The U.S. Department of Health and Human Services took one small toke for man, and one giant bong rip for mankind this week as the agency seeks to ease longstanding marijuana restrictions. Health and ...

WASHINGTON — U.S. Rep. Greg Steube, a Republican congressman from Sarasota, has refiled a bill to change the way marijuana is classified at the federal level. It's called the "Marijuana 1-to-3 Act," ...

McCormick said in a press conference Thursday that he was concerned nitazenes “would become the next fentanyl,” the opioid behind a massive rise in overdose deaths across the U.S.

The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that ...

The DEA’s move to reclassify cannabis must first be reviewed by the White House Office of Management and Budget (OMB), and for the first time in 50 years would recognize the medical uses of cannabis.

Cannabis may be on its way to being less restricted in the U.S. after a recent recommendation from the Health and Human Services Department to reschedule the drug's classification. Last week, the HHS ...

The DEA recently added six "new" synthetic cannabinoids to its Schedule I list of illegal drugs (aka Spice, K2, bath salts). Has doing this ever worked in the past? No. Will it work now? Of course not ...

The House on Thursday approved a bill that would classify all fentanyl as a Schedule 1 substance, the most dangerous classification of drugs. The GOP-led legislation, backed by the White House, passed ...

CCo announces that the U.S. Drug Enforcement Administration has classified Vyvanse, as a Schedule II controlled substance, following the earlier recommendation of the U.S.FDA. The DEA schedule ...